Literature DB >> 27522374

Ethical issues in nanomedicine: Tempest in a teapot?

Irit Allon1,2, Ahmi Ben-Yehudah3, Raz Dekel4, Jan-Helge Solbakk5, Klaus-Michael Weltring6, Gil Siegal7,8,9.   

Abstract

Nanomedicine offers remarkable options for new therapeutic avenues. As methods in nanomedicine advance, ethical questions conjunctly arise. Nanomedicine is an exceptional niche in several aspects as it reflects risks and uncertainties not encountered in other areas of medical research or practice. Nanomedicine partially overlaps, partially interlocks and partially exceeds other medical disciplines. Some interpreters agree that advances in nanotechnology may pose varied ethical challenges, whilst others argue that these challenges are not new and that nanotechnology basically echoes recurrent bioethical dilemmas. The purpose of this article is to discuss some of the ethical issues related to nanomedicine and to reflect on the question whether nanomedicine generates ethical challenges of new and unique nature. Such a determination should have implications on regulatory processes and professional conducts and protocols in the future.

Keywords:  Enhancement; Ethics; Nanomedicine; Nanotechnology; Risk; Safety; Social justice; Uncertainty

Mesh:

Year:  2017        PMID: 27522374     DOI: 10.1007/s11019-016-9720-7

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  38 in total

1.  Public health ethics: mapping the terrain.

Authors:  James F Childress; Ruth R Faden; Ruth D Gaare; Lawrence O Gostin; Jeffrey Kahn; Richard J Bonnie; Nancy E Kass; Anna C Mastroianni; Jonathan D Moreno; Phillip Nieburg
Journal:  J Law Med Ethics       Date:  2002       Impact factor: 1.718

2.  Extending clinical equipoise to phase 1 trials involving patients: unresolved problems.

Authors:  James A Anderson; Jonathan Kimmelman
Journal:  Kennedy Inst Ethics J       Date:  2010-03

3.  Ethical issues in clinical trials involving nanomedicine.

Authors:  David B Resnik; Sally S Tinkle
Journal:  Contemp Clin Trials       Date:  2006-11-17       Impact factor: 2.226

4.  Nanomedicine-emerging or re-emerging ethical issues? A discussion of four ethical themes.

Authors:  Christian Lenk; Nikola Biller-Andorno
Journal:  Med Health Care Philos       Date:  2006-08-30

Review 5.  Resolving the nanoparticles paradox.

Authors:  Ken Donaldson
Journal:  Nanomedicine (Lond)       Date:  2006-08       Impact factor: 5.307

6.  The tragedy of translation: the case of "first use" in human embryonic stem cell research.

Authors:  Jan Helge Solbakk; Laurie Zoloth
Journal:  Cell Stem Cell       Date:  2011-05-06       Impact factor: 24.633

Review 7.  Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges.

Authors:  Helinor Johnston; Giulio Pojana; Stefano Zuin; Nicklas Raun Jacobsen; Peter Møller; Steffen Loft; Manuela Semmler-Behnke; Catherine McGuiness; Dominique Balharry; Antonio Marcomini; Håkan Wallin; Wolfgang Kreyling; Ken Donaldson; Lang Tran; Vicki Stone
Journal:  Crit Rev Toxicol       Date:  2012-11-06       Impact factor: 5.635

Review 8.  Testing metal-oxide nanomaterials for human safety.

Authors:  Robert Landsiedel; Lan Ma-Hock; Alexandra Kroll; Daniela Hahn; Jürgen Schnekenburger; Karin Wiench; Wendel Wohlleben
Journal:  Adv Mater       Date:  2010-06-25       Impact factor: 30.849

Review 9.  Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles.

Authors:  Günter Oberdörster; Eva Oberdörster; Jan Oberdörster
Journal:  Environ Health Perspect       Date:  2005-07       Impact factor: 9.031

10.  Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells.

Authors:  Marianne Geiser; Barbara Rothen-Rutishauser; Nadine Kapp; Samuel Schürch; Wolfgang Kreyling; Holger Schulz; Manuela Semmler; Vinzenz Im Hof; Joachim Heyder; Peter Gehr
Journal:  Environ Health Perspect       Date:  2005-11       Impact factor: 9.031

View more
  4 in total

1.  Emerging technologies and the voice of reason.

Authors:  Bert Gordijn; Henk Ten Have
Journal:  Med Health Care Philos       Date:  2017-03

Review 2.  Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities.

Authors:  Fatemeh Farjadian; Amir Ghasemi; Omid Gohari; Amir Roointan; Mahdi Karimi; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2018-11-19       Impact factor: 5.307

3.  Important ethical issues for nanomedicine.

Authors:  Sora Yasri; Viroj Wiwanitkit
Journal:  J Res Med Sci       Date:  2017-12-26       Impact factor: 1.852

Review 4.  An Elucidative Review to Analytically Sieve the Viability of Nanomedicine Market.

Authors:  Anaida Kad; Archit Pundir; Shailendra Kumar Arya; Neha Bhardwaj; Madhu Khatri
Journal:  J Pharm Innov       Date:  2020-09-21       Impact factor: 2.538

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.